These final results, together with a past report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 support the idea of targeting ACKR3 as a singular method to modulate the opioid system, which could open new therapeutic avenues for opioid-similar Diseases. These outcomes propose that conolidine https://dennisl627hzp2.wikififfi.com/user